Tekla Capital Management LLC Glaukos Corp Transaction History

Tekla Capital Management LLC

  • $2.53 Billion
  • Q2 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 13, 2018
SELL
$27.62 - $44.51 $1.52 Million - $2.45 Million
-55,079 Closed
0 $0
Q4 2017

Feb 14, 2018
SELL
$24.5 - $36.01 $211,386 - $310,694
-8,628 Reduced 13.54%
55,079 $1.41 Million
Q3 2017

Nov 13, 2017
BUY
$31.26 - $42.03 $1.99 Million - $2.68 Million
63,707
63,707 $2.1 Million

Others Institutions Holding GKOS

# of Institutions
303
Shares Held
47M
Call Options Held
75.3K
Put Options Held
157K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.11B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email